Business Description
HeartSciences Inc. is a Texas-based medical technology company that uses artificial intelligence to make heart testing more effective. Its main product, the MyoVista wavECG, is a standard 12-lead ECG device that can detect early signs of cardiac dysfunction while also performing routine heart tests at the same time. The company also offers a cloud-based platform called MyoVista Insights, which allows its AI-driven tools to work across different ECG hardware. Founded in 2007 and previously known as Heart Test Laboratories Inc., the company rebranded under its current name in October 2024.
